These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21098846)

  • 61. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice.
    Benacerraf BR
    Prenat Diagn; 2010 Jul; 30(7):644-52. PubMed ID: 20572106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening.
    Palomaki GE; Knight GJ; Neveux LM; Pandian R; Haddow JE
    Clin Chem; 2005 Aug; 51(8):1499-504. PubMed ID: 15961547
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Correlation of second-trimester sonographic and biochemical markers.
    Souter VL; Nyberg DA; Benn PA; Zebelman A; Luthardt F; Luthy DA
    J Ultrasound Med; 2004 Apr; 23(4):505-11. PubMed ID: 15098869
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transvaginal sonographic examination of the fetal nasal bone is unable to predict Down syndrome at 14-16 weeks' gestation.
    Bronshtein M; Blazer S; Zimmer EZ
    Ultrasound Obstet Gynecol; 2005 Jun; 25(6):625-7. PubMed ID: 15909314
    [No Abstract]   [Full Text] [Related]  

  • 65. [Diagnostic methods for fetal malformations in the first half of pregnancy].
    Sieroszewski P; Suzin J; Baś-Budecka E
    Ginekol Pol; 2003 Oct; 74(10):1276-83. PubMed ID: 14669430
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correlation between nuchal translucency and nuchal skin-fold measurements in Down syndrome and unaffected fetuses.
    Maymon R; Zimerman AL; Weinraub Z; Herman A; Cuckle H
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):501-5. PubMed ID: 18512852
    [TBL] [Abstract][Full Text] [Related]  

  • 67. First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA.
    Johnson J; Pastuck M; Metcalfe A; Connors G; Krause R; Wilson D; Cuckle H
    Prenat Diagn; 2013 Nov; 33(11):1044-9. PubMed ID: 23836291
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Second-trimester biparietal diameter/nasal bone length ratio is an independent predictor of trisomy 21.
    Tran LT; Carr DB; Mitsumori LM; Uhrich SB; Shields LE
    J Ultrasound Med; 2005 Jun; 24(6):805-10. PubMed ID: 15914684
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nuchal translucency thickness measurements for fetal aneuploidy screening: Log NT-MoM or Delta-NT, performer-specific medians and ultrasound training.
    Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; Ombelet WU; Nijhuis JG
    J Med Screen; 2006; 13(1):4-7. PubMed ID: 16569298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21.
    Bunduki V; Ruano R; Miguelez J; Yoshizaki CT; Kahhale S; Zugaib M
    Ultrasound Obstet Gynecol; 2003 Feb; 21(2):156-60. PubMed ID: 12601838
    [TBL] [Abstract][Full Text] [Related]  

  • 71. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.
    Ghaffari SR; Tahmasebpour AR; Jamal A; Hantoushzadeh S; Eslamian L; Marsoosi V; Fattahi F; Rajaei M; Niroomanesh S; Borna S; Beigi A; Khazardoost S; Saleh-Gargari S; Rahimi-Sharbaf F; Farrokhi B; Bayani N; Tehrani SE; Shahsavan K; Farzan S; Moossavi S; Ramezanzadeh F; Dastan J; Rafati M
    Ultrasound Obstet Gynecol; 2012 May; 39(5):528-34. PubMed ID: 21793085
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early genetic sonogram for Down syndrome detection.
    Bahado-Singh RO; Mendilcioglu I; Rowther M; Choi SJ; Oz U; Yousefi NF; Mahoney MJ
    Am J Obstet Gynecol; 2002 Nov; 187(5):1235-8. PubMed ID: 12439511
    [TBL] [Abstract][Full Text] [Related]  

  • 73. First-trimester screening for Down syndrome with ductus venosus Doppler studies in addition to nuchal translucency and serum markers.
    Borrell A; Gonce A; Martinez JM; Borobio V; Fortuny A; Coll O; Cuckle H
    Prenat Diagn; 2005 Oct; 25(10):901-5. PubMed ID: 16034840
    [TBL] [Abstract][Full Text] [Related]  

  • 74. First-trimester screening in triplets.
    Krantz DA; Hallahan TW; He K; Sherwin JE; Evans MI
    Am J Obstet Gynecol; 2011 Oct; 205(4):364.e1-5. PubMed ID: 22083057
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome.
    Wang M; Lu S; Zhu Y; Li H
    Prenat Diagn; 2010 Jun; 30(6):561-4. PubMed ID: 20509157
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Sonographic first trimester screening in Switzerland].
    Lapaire O; Sartorius G; Holzgreve W; Tercanli S
    Praxis (Bern 1994); 2005 Feb; 94(6):199-204. PubMed ID: 15754531
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Additional first-trimester ultrasound markers.
    Sonek J; Nicolaides K
    Clin Lab Med; 2010 Sep; 30(3):573-92. PubMed ID: 20638573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.